Catch up with our insights on the big issues in pharma.
Our thought leadership library brings you our latest data-driven reports, infographics and articles that tackle the big issues, interesting niches and everything in between.
The Latest Best Estimate keeps a commercial plan honest through the year. From how to define the right LBE cadence, to making risk and opportunities explicit in your forecasting, this article sets out...
AI adoption in pharmaceutical commercialization is accelerating but results are uneven, confidence is often misplaced, and most teams are using tools that were never built for the decisions they're making....
Most commercial pharma teams are running AI experiments and almost none are getting results they can stake a real decision on. This infographic draws on exclusive survey data from 150 senior biopharma...
The Annual Operating Plan is the financial and strategic baseline for everything that follows. Get it wrong in January and you spend the rest of the year reacting. The same mistakes are common, but none...
Oncology accounts for around 18% of global drug sales. By 2032, Evaluate Pharma puts the oncology market forecast at close to $400bn. But the landscape is evolving. Patent cliffs threaten today’s leaders,...
Over 20,000 biopharma professionals gathered in San Diego for four days of dealmaking, debate, and a few hard truths about where the industry is headed.
Evaluate's BIO International 2026 infographic pulls toget...
